Piero Fossati

European Institute of Oncology, University of Milan

Papers

2

Total Citations

46

H-Index

2

About

Piero Fossati is a leading figure in the field of radiation oncology, with a primary focus on advanced particle therapy and stereotactic radiosurgery. His major contributions center on the clinical implementation and validation of cutting-edge technologies for treating cancer. Notably, he played a pivotal role in the early clinical experience at the Italian National Center for Hadrontherapy (CNAO), reporting the first toxicity data for scanned proton beams in 2013—a foundational study that demonstrated the safety and feasibility of this precise modality for treating challenging tumors like chondrosarcomas. This work, cited 18 times, helped establish protocols for proton therapy in Europe. Additionally, his research on CyberKnife robotic stereotactic radiotherapy for oligometastatic cancer (28 citations) has advanced the understanding of non-invasive, image-guided ablation for limited metastatic disease. Through these contributions, Fossati has shaped modern approaches to delivering high-dose, targeted radiation while minimizing damage to healthy tissue, solidifying his reputation as a pioneer in translating complex physics into tangible patient benefits.

Research Focus

Key Achievements

2
H-Index
2
Papers
46
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
CyberKnife robotic image-guided stereotactic radiotherapy for oligometastic cancer
28 citations · 2013
📈 Most Prolific Year: 2013 (2 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: European Institute of Oncology, University of Milan

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago